NORLIQVA FDA approval date

The FDA approved NORLIQVA on 24 Feb 2022.

FDA approval date
24 Feb 2022

Drug identity has not yet been verified against registry records

Also recorded as AMLODIPINE BESYLATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-02-24DayNORLIQVAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA214439", "applicant_as_listed_by_fda": "CMP DEV LLC", "brand_names": ["NORLIQVA"], "active_ingredients": ["AMLODIPINE BESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220224", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026